NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+11.33%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.02B
AUM Growth
+$1.02B
(+2.2%)
Cap. Flow
-$87.8M
Cap. Flow
% of AUM
-8.6%
Top 10 Holdings %
Top 10 Hldgs %
46.08%
Holding
137
New
19
Increased
22
Reduced
37
Closed
18
Top Buys
| 1 |
Peloton Interactive
PTON
|
$13.1M |
| 2 |
Tourmaline Bio
TRML
|
$6.64M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$6.6M |
| 4 |
eHealth
EHTH
|
$5.55M |
| 5 |
CONN
Conn's Inc.
CONN
|
$4.73M |
Top Sells
| 1 |
Establishment Labs
ESTA
|
$25.7M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$19.7M |
| 3 |
Soleno Therapeutics
SLNO
|
$19.1M |
| 4 |
Luxfer Holdings
LXFR
|
$11.7M |
| 5 |
Cytokinetics
CYTK
|
$9.19M |
Sector Composition
| 1 | Healthcare | 63.23% |
| 2 | Consumer Discretionary | 13.84% |
| 3 | Financials | 7.05% |
| 4 | Communication Services | 5.88% |
| 5 | Technology | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Soleno Therapeutics
SLNO
$3.6B
| $103M | 5.89% | 2,410,379 -445,972 | -16% | -$19.1M |
|
|
2
Establishment Labs
ESTA
$1.2B
| $100M | 5.71% | 1,964,562 -505,592 | -20% | -$25.7M |
|
3
Pathward Financial
CASH
$1.82B
| $51.6M | 2.95% | 1,021,727 -38,139 | -4% | -$1.93M |
|
4
Evolus
EOLS
$494M
| $40.8M | 2.33% | 2,910,849 | – | – |
|
5
IMAX
IMAX
$1.54B
| $35.6M | 2.04% | 2,203,177 -205,576 | -9% | -$3.32M |
|
6
Hilton Grand Vacations
HGV
$4.24B
| $31.6M | 1.8% | 668,871 -2,300 | -0.3% | -$109K |
|
7
Bioventus
BVS
$495M
| $30.2M | 1.72% | 5,806,012 -171,459 | -3% | -$892K |
|
|
RDNW
8
RideNow Group, Inc. Class B Common Stock
RDNW
$147M
| $28.5M | 1.63% | 4,416,506 | – | – |
|
|
9
Peloton Interactive
PTON
$3.1B
| $27.1M | 1.55% | 6,312,939 +3,050,000 | +93% | +$13.1M |
|
10
Red Violet
RDVT
$702M
| $21.8M | 1.25% | 1,116,249 -89,429 | -7% | -$1.75M |
|
11
America's Car Mart
CRMT
$371M
| $19.9M | 1.14% | 312,128 | – | – |
|
12
Keros Therapeutics
KROS
$618M
| $19.5M | 1.11% | 293,997 -16,144 | -5% | -$1.07M |
|
13
Lyra Therapeutics
LYRA
$11.5M
| $17.5M | 1% | 2,820,982 -1,229,236 | -30% | -$7.65M |
|
14
Abeona Therapeutics
ABEO
$350M
| $16.8M | 0.96% | 2,310,640 +60,388 | +3% | +$438K |
|
15
uniQure
QURE
$896M
| $16.1M | 0.92% | 3,088,082 +130,055 | +4% | +$676K |
|
|
16
Tourmaline Bio
TRML
$601M
| $16.1M | 0.92% | 700,907 +290,000 | +71% | +$6.64M |
|
17
Amneal Pharmaceuticals
AMRX
$3B
| $15.9M | 0.91% | 2,619,943 +285,546 | +12% | +$1.73M |
|
18
Codexis
CDXS
$246M
| $15.6M | 0.89% | 4,461,878 -131,025 | -3% | -$457K |
|
19
Viemed Healthcare
VMD
$286M
| $14.6M | 0.84% | 1,550,122 -402,246 | -21% | -$3.79M |
|
20
DXP Enterprises
DXPE
$1.96B
| $14.5M | 0.83% | 269,806 +67,977 | +34% | +$3.65M |
|
|
ABVX
21
Abivax
ABVX
$6.12B
| $14.4M | 0.83% | 1,010,034 | – | – |
|
22
Zevra Therapeutics
ZVRA
$509M
| $14.2M | 0.81% | 2,453,405 | – | – |
|
23
Dyne Therapeutics
DYN
$1.92B
| $12.4M | 0.71% | 435,256 -207,533 | -32% | -$5.89M |
|
24
Reservoir Media
RSVR
$517M
| $12.3M | 0.7% | 1,550,797 | – | – |
|
|
25
eHealth
EHTH
$118M
| $11.5M | 0.66% | 1,911,821 +920,000 | +93% | +$5.55M |
|